Corona Remedies Ltd

CORONA

Company Profile

  • Business description

    Corona Remedies Ltd is mainly engaged in the business of manufacturing, trading and marketing of Pharmaceutical products. It is engaged in developing, manufacturing and marketing products in women's healthcare, cardio-diabetes, pain management, urology and other segments, such as Vitamin Minerals and Nutrients(VMN), gastrointestinal and respiratory therapies. The company's brands are B-29, myoril, Tricium, Cortel, and Obimet. The Company has only one reportable business segment i.e. Pharmaceuticals. The company has presence in India as well as Outside India. The company generates majority of revenue from India.

  • Contact

    S. G. Highway, CORONA House
    C - Mondeal Business Park, Near Gurudwara
    Thaltej
    AhmedabadGJ380 059
    IND

    T: +91 7940233000

    https://www.coronaremedies.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 March 2027

    Employees

    5,686

Stocks News & Analysis

stocks

ASX major bank drives strong quarterly profit

Profit momentum remains robust yet shares overvalued.
stocks

Ask the analyst: What to expect in earnings season?

The key metrics that matter this earnings season.
stocks

ASX healthcare share remains undervalued ahead of earnings

Margin recovery remains the key driver for this ASX healthcare share.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,063.8036.200.40%
CAC 408,439.0666.780.80%
DAX 4025,492.67393.671.57%
Dow JONES (US)51,947.25235.600.46%
FTSE 10010,791.4355.200.51%
HKSE25,207.18243.950.98%
NASDAQ24,975.82161.87-0.64%
Nikkei 22564,931.19320.040.50%
NZX 50 Index13,850.6978.400.57%
S&P 5007,411.983.680.05%
S&P/ASX 2008,894.0036.100.41%
SSE Composite Index3,858.2544.051.15%

Market Movers